UnicoCell Biomed Revenue

In the year 2025, UnicoCell Biomed had annual revenue of 30.10M TWD, down -5.58%. UnicoCell Biomed had revenue of 6.36M in the quarter ending December 31, 2025, a decrease of -41.33%.

Revenue

30.10M

Revenue Growth

-5.58%

P/S Ratio

165.29

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.98B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.10M	-1.78M	-5.58%
Dec 31, 2024	31.88M	7.29M	29.66%
Dec 31, 2023	24.59M	10.19M	70.79%
Dec 31, 2022	14.40M	6.22M	76.07%
Dec 31, 2021	8.18M	4.20M	105.35%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pharmosa Biopharm	136.72M
OBI Pharma	49.29M
Panion & Bf Biotech	2.04B
Locus Cell	5.18M
AnnJi Pharmaceutical	23.85M
CHO Pharma	3.21M
Senhwa Biosciences	1.08M
BioGend Therapeutics	222.34M

Revenue Rankings